St. Jude Medical, having received approval in U.S., Europe, and other markets, is releasing its new high-voltage Optisure defibrillation lead. The device is based on the company’s Durata lead, but with extra insulation at the proximal end of the lead.
It’s compatible with all St. Jude Medical implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy defibrillators (CRT-D).
More about the new lead from the announcement:
Based on the established Durata lead design, the Optisure lead features additional Optim insulation at the proximal end of the lead, including under the superior vena cava (SVC) shock coil. The lead design is identical to Durata distal to the SVC shock coil. Optim insulation is a hybrid insulation material unique toSt. Jude Medical and created specifically for cardiac leads. It blends the biostability and flexibility of high-performance silicone rubber with the strength, tear resistance and abrasion resistance of polyurethane to provide increased durability, along with the flexibility and handling characteristics that facilitate device implantation. With both 7 and 8 French diameter leads, the St. Jude Medical high-voltage portfolio now provides physicians more treatment options to tailor therapy to individualized patient needs.
The Optisure defibrillation lead is compatible with all of the company’s implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds), including the company’s next-generation Ellipse™ and SJM Assura™ portfolio of ICDs and CRT-Ds.
Product page: Optisure Defibrillation Lead…